Effectiveness and Safety of Tofacitinib in Patients With Extensive and Recalcitrant Alopecia Areata

NCT03800979 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

19

Enrollment

OTHER_GOV

Sponsor class

Conditions

Alopecia Areata

Interventions

DRUG: Tofacitinib

Sponsor

Institute of Dermatology, Thailand